Ads
related to: bms eliquis patient assistance formSCBN.org has been visited by 10K+ users in the past month
uslegalforms.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
[30] [31] In August 2014, the FDA approved apixaban for the additional indication of the treatment of recurring deep vein thrombosis and pulmonary embolism. [30] [32] During its development the drug was known as BMS-562247-01. [33] By late 2019, sales of the product by BMS accounted for thirty percent of their quarterly revenue. [34]
A person also can look for other pharmaceutical assistance programs using Medicare’s online tool. Additionally, people with Medicare may want to consider the following options:
Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain. [2]
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey , [ 2 ] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
U.S. FDA Approves ELIQUIS ® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation ELIQUIS Demonstrated Superior Risk Reductions Versus ...
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: bms eliquis patient assistance formSCBN.org has been visited by 10K+ users in the past month
uslegalforms.com has been visited by 100K+ users in the past month